A wealth of clinical evidence and published study data support the benefits of EVH therapy.

Most recently, a study was published in the Journal of the American Medical Association that found EVH was not associated with either increased mortality or increased adverse cardiac events at three years—a huge win for EVH. After years of debate, this study finally reaffirms the safety of EVH therapy in the face of concerns raised by the 2009 PREVENT IV subset analysis.10

Below you’ll find the latest data and debates impacting vein harvesters and surgeons (complete articles can be obtained through online medical reference services).

• NEW EVH DATA
• ABSTRACTS & PAPERS
• LIBRARY